Stifel Nicolaus Downgrades Kura Oncology (NASDAQ:KURA) to Hold
Stifel Nicolaus downgraded shares of Kura Oncology (NASDAQ:KURA – Free Report) from a buy rating to a hold rating in a report published on Monday morning, MarketBeat reports. They currently have $19.00 price objective on the stock, down from their previous price objective of $26.00. A number of other equities analysts also recently commented on […]
More Stories
OFG Bancorp (NYSE:OFG) Issues Quarterly Earnings Results
OFG Bancorp (NYSE:OFG – Get Free Report) posted its quarterly earnings data on Wednesday. The bank reported $1.00 earnings per...
Abbott Laboratories (NYSE:ABT) Announces Earnings Results, Beats Estimates By $0.01 EPS
Abbott Laboratories (NYSE:ABT – Get Free Report) released its quarterly earnings results on Wednesday. The healthcare product maker reported $1.21...
Home Bancshares, Inc. (Conway, AR) (NYSE:HOMB) Issues Quarterly Earnings Results
Home Bancshares, Inc. (Conway, AR) (NYSE:HOMB – Get Free Report) announced its earnings results on Wednesday. The financial services provider...
U.S. Bancorp (NYSE:USB) Announces Earnings Results
U.S. Bancorp (NYSE:USB – Get Free Report) issued its earnings results on Wednesday. The financial services provider reported $1.03 EPS...
Abbott Laboratories (NYSE:ABT) Updates FY 2024 Earnings Guidance
Abbott Laboratories (NYSE:ABT – Get Free Report) updated its FY 2024 earnings guidance on Wednesday. The company provided EPS guidance...
Just Eat Takeaway.com (OTC:JTKWY) Lifted to Hold at Sanford C. Bernstein
Just Eat Takeaway.com (OTC:JTKWY – Get Free Report) was upgraded by investment analysts at Sanford C. Bernstein to a “hold”...